200 related articles for article (PubMed ID: 34976980)
1. Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.
Karamitros CS; Somody CM; Agnello G; Rowlinson S
Front Bioeng Biotechnol; 2021; 9():793985. PubMed ID: 34976980
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy.
Levene M; Bain MD; Moran NF; Nirmalananthan N; Poulton J; Scarpelli M; Filosto M; Mandel H; MacKinnon AD; Fairbanks L; Pacitti D; Bax BE
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959750
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.
Frontiers Production Office
Front Bioeng Biotechnol; 2022; 10():878674. PubMed ID: 35360397
[TBL] [Abstract][Full Text] [Related]
4. Rational surface engineering of an arginine deiminase (an antitumor enzyme) for increased PEGylation efficiency.
Cheng F; Yang J; Schwaneberg U; Zhu L
Biotechnol Bioeng; 2019 Sep; 116(9):2156-2166. PubMed ID: 31062871
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.
Yadak R; Sillevis Smitt P; van Gisbergen MW; van Til NP; de Coo IF
Front Cell Neurosci; 2017; 11():31. PubMed ID: 28261062
[TBL] [Abstract][Full Text] [Related]
6. Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy.
Levene M; Pacitti D; Gasson C; Hall J; Sellos-Moura M; Bax BE
Mol Ther Methods Clin Dev; 2018 Dec; 11():1-8. PubMed ID: 30294618
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial.
Bax BE; Levene M; Bain MD; Fairbanks LD; Filosto M; Kalkan Uçar S; Klopstock T; Kornblum C; Mandel H; Rahman S; Roubertie A; Scarpelli M; Sedgwick PM; Baru M; Sellos-Moura M; Price J; Horn P; Nirmalananthan N
J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344955
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.
Halter JP; Michael W; Schüpbach M; Mandel H; Casali C; Orchard K; Collin M; Valcarcel D; Rovelli A; Filosto M; Dotti MT; Marotta G; Pintos G; Barba P; Accarino A; Ferra C; Illa I; Beguin Y; Bakker JA; Boelens JJ; de Coo IF; Fay K; Sue CM; Nachbaur D; Zoller H; Sobreira C; Pinto Simoes B; Hammans SR; Savage D; Martí R; Chinnery PF; Elhasid R; Gratwohl A; Hirano M
Brain; 2015 Oct; 138(Pt 10):2847-58. PubMed ID: 26264513
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.
Bax BE
J Transl Genet Genom; 2020 Mar; 4():1-16. PubMed ID: 32914088
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.
Slama A; Lacroix C; Plante-Bordeneuve V; Lombès A; Conti M; Reimund JM; Auxenfants E; Crenn P; Laforêt P; Joannard A; Seguy D; Pillant H; Joly P; Haut S; Messing B; Said G; Legrand A; Guiochon-Mantel A
Mol Genet Metab; 2005 Apr; 84(4):326-31. PubMed ID: 15781193
[TBL] [Abstract][Full Text] [Related]
11. Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy.
Boschetti E; D'Alessandro R; Bianco F; Carelli V; Cenacchi G; Pinna AD; Del Gaudio M; Rinaldi R; Stanghellini V; Pironi L; Rhoden K; Tugnoli V; Casali C; De Giorgio R
PLoS One; 2014; 9(5):e96692. PubMed ID: 24802030
[TBL] [Abstract][Full Text] [Related]
12. Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.
De Vocht C; Ranquin A; Willaert R; Van Ginderachter JA; Vanhaecke T; Rogiers V; Versées W; Van Gelder P; Steyaert J
J Control Release; 2009 Aug; 137(3):246-54. PubMed ID: 19371766
[TBL] [Abstract][Full Text] [Related]
13. Discovery profiling and bioinformatics analysis of serum microRNA in Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE).
Levene M; Enguita FJ; Bax BE
Nucleosides Nucleotides Nucleic Acids; 2018; 37(11):618-629. PubMed ID: 30587073
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal.
Yadak R; Breur M; Bugiani M
Orphanet J Rare Dis; 2019 Feb; 14(1):33. PubMed ID: 30736844
[TBL] [Abstract][Full Text] [Related]
15. Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE.
Meinders M; Shoemark D; Dobbe JGG; Streekstra GJ; Frayne J; Toye AM
Mol Ther Methods Clin Dev; 2020 Jun; 17():822-830. PubMed ID: 32368563
[TBL] [Abstract][Full Text] [Related]
16. MNGIE: from nuclear DNA to mitochondrial DNA.
Nishino I; Spinazzola A; Hirano M
Neuromuscul Disord; 2001 Jan; 11(1):7-10. PubMed ID: 11166160
[TBL] [Abstract][Full Text] [Related]
17. Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.
Taha M; Rashid U; Imran S; Ali M
Bioorg Med Chem; 2018 Jul; 26(12):3654-3663. PubMed ID: 29853339
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Neurogastrointestinal Encephalomyopathy Disease in Three Siblings from Pakistan with a Novel Mutation.
Durrani S; Chen BC; Yakob Y; Hian LS; Afroze B
J Pediatr Genet; 2019 Mar; 8(1):15-19. PubMed ID: 30775048
[TBL] [Abstract][Full Text] [Related]
19. Altered thymidine metabolism due to defects of thymidine phosphorylase.
Spinazzola A; Marti R; Nishino I; Andreu AL; Naini A; Tadesse S; Pela I; Zammarchi E; Donati MA; Oliver JA; Hirano M
J Biol Chem; 2002 Feb; 277(6):4128-33. PubMed ID: 11733540
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel
Paisiou A; Rogalidou M; Pons R; Ioannidou E; Dimakou K; Papadopoulou A; Vaz FM; Vessalas G; Goorden SMI; Roelofsen J; Zoetekouw A; Nieman MM; Dimitriou E; Moraitou M; Peristeri I; Michelakakis H; van Kuilenburg ABP
Mol Genet Metab Rep; 2022 Mar; 30():100829. PubMed ID: 34926160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
